The BLS Occupational Employment and Wage Statistics report for May 2024 puts the mean annual wage for nurse practitioners at $132,050. That is the baseline.
Before you set a commission rate, assign a production threshold, or decide between salary and commission, that number needs to be the anchor in your model.
What most owners underestimate is what happens when you add FICA, benefits, and consumable costs on top of it, and then run the math at current utilization. The result is often a contribution margin that is half what the compensation structure was designed to produce.
Injector compensation is where med spa P&Ls get complicated fastest. The rate you set matters less than how you define the base. Gross revenue, net of consumables, and tiered commission all produce different outcomes from the same injector and the same client volume. Getting the structure wrong does not show up as a single bad month. It shows up as a practice that grows revenue and watches margin compress at the same time.
What is the average injector commission at a medical spa?
Most med spa injector commission rates fall between 20% and 30% of provider revenue. The specific rate depends on whether the commission applies to gross revenue or net of consumables, and whether there is a base salary underneath it. At 20% on gross revenue, a provider generating $400,000 per year takes home $80,000 in commissions.
At 20% on net of consumables, with injectable COGS at 40%, the same provider earns $48,000 in commissions. That $32,000 difference is not a rounding error. It is the difference between a compensation structure that works and one that slowly breaks your gross margin.
Zenoti data shows average med spa staff utilization at 47%, with top performers reaching 78%. At a $164 average ticket, a provider at 47% utilization generates roughly $200,000 to $280,000 in annual revenue. That changes the commission math significantly compared to the $400,000 examples circulating in industry conversations.
The three compensation models: how they compare
There is no single right answer, but there is a model that fits your revenue tier and risk tolerance. The table below compares the three most common structures across the dimensions that matter operationally and financially.
| Model | Best For | Risk to Practice | Compliance Exposure |
|---|---|---|---|
| Straight salary | New injectors, ramp periods, low-volume practices | High — fixed cost regardless of production | Low — W-2 structure is clear |
| Base + commission | Established injectors at $200K+ annual revenue | Moderate — base is fixed, upside is earned | Low — W-2, structured correctly |
| Straight commission | High-volume injectors with established books | Low — cost scales with revenue | High — misclassification risk in many states |
The base-plus-commission model earns the most column greens because it aligns incentives without creating income instability that causes provider turnover, and it keeps the practice's legal posture clean. Straight commission looks attractive on a spreadsheet because the cost scales with revenue, but it introduces two risks most owners do not price in: provider attrition during slow months, and employment law exposure that can result in back-tax liability.
How to calculate net of consumables commission
Net of consumables commission is the structure that protects gross margin regardless of what your injectors are using. The formula removes injectable COGS from the commission base before the rate is applied. Your cost of product is always covered first, and the commission is calculated on the value the provider actually created, not the revenue that includes your supply spend.
The injectable COGS benchmark for medical spas is 30 to 40% of injectable revenue. At the high end of that range, the difference between gross and net commission is significant enough to change whether your compensation model is viable.
The $32,000 difference between gross and net commission is not just a number on this page. At a practice with two injectors and $800,000 in combined injectable revenue, that is a $64,000 difference in annual labor cost. That is often the difference between hitting 25% contribution margin and running below 20%.
What the fully loaded cost actually looks like
The BLS mean NP wage of $132,050 is not the number in your P&L. Add employer FICA at 7.65% and a standard benefits load, and the fully loaded annual cost reaches approximately $151,858.
That is the figure to use when modeling contribution margin, not the base wage. Using the base wage makes your provider economics look cleaner than they are, and that gap is where practices get surprised when they finally run a real P&L.
At $164 average ticket and a 25% target contribution margin after COGS and direct compensation, a full-time NP needs approximately 51 treatments per week to clear that threshold at BLS wages. Zenoti data puts average staff utilization at 47%, which translates to roughly 38 treatments per week at full-time hours.
The injectors are not the problem. The model that assumes 78% utilization when you are running at 47% is the problem. Fix the model before you adjust the rate.
How to set the production threshold in a base-plus-commission structure
The threshold is the point at which commission begins. Below it, the provider earns their base salary. Above it, they earn base plus commission on every dollar over the threshold.
The threshold should be set at the revenue level where the practice recovers the fully loaded base salary cost and hits at minimum a 20% contribution margin. Below that point, paying commission on top of salary accelerates a loss. Above that point, commission is earned from value that genuinely exists in the P&L.
A practical approach: divide the fully loaded annual provider cost by your gross margin after COGS to find the revenue needed to break even on the provider. Set the threshold 10 to 15% above that figure to create a buffer.
What to track monthly
- Provider revenue by treatment category, separated from retail and device revenue
- Injectable COGS allocated by provider, not just as a practice-wide line
- Utilization rate versus the threshold assumption used when the compensation was modeled
- Contribution margin per provider, updated monthly, not quarterly
The employment law risk most owners do not know about
Straight commission structures for licensed healthcare providers, nurse practitioners, physician assistants, and registered nurses, create W-2 versus 1099 misclassification risk in many states.
California, New York, New Jersey, and Massachusetts apply multi-factor tests that typically require a worker to operate independently of the hiring entity's control. A licensed injector working under your medical director's supervision, using your protocols, treating your patients, and working exclusively in your location almost certainly fails that test.
Several med spas have received back-tax assessments and penalties for misclassifying NPs and PAs as 1099 contractors. Consult a healthcare employment attorney before using a straight-commission 1099 structure for any licensed clinical provider. For a full breakdown of the IRS three-factor test, commission structures under each model, and the break-even revenue threshold, see 1099 vs W-2 injector: what the numbers actually show.
Which model fits your revenue tier
Below $150,000 in annual provider revenue, a straight salary protects the practice from paying commission on volume that has not yet covered fixed overhead. Between $150,000 and $300,000, the base-plus-commission model starts to make financial sense.
Above $300,000, a well-structured net-of-consumables commission model at 20 to 25% can work cleanly if the COGS are tracked accurately by provider and the threshold is set correctly. The risk at this tier is not the commission itself. It is poor COGS tracking that causes the net commission base to be overstated.
Above $500,000 in annual provider revenue, profit-sharing tied to contribution margin is worth considering as a layer on top of base plus commission. This aligns the provider directly with practice profitability, not just gross output, and creates an incentive to manage supply use as well as volume.
The benchmark most practices are missing
Target provider contribution margin is 25 to 35% after COGS and direct compensation. Below 20% is a warning signal that requires a compensation structure review, a utilization review, or a COGS audit, usually some combination of all three.
Most practices that run below 20% are not paying too much in commissions. They are using COGS rates that are too high and commission bases that are gross rather than net. Fixing the structure before adjusting the rate usually recovers more margin than simply cutting the percentage.
See your real provider contribution margin, calculated from your actual books.
Spa Ledger builds a weekly P&L that separates provider revenue, injectable COGS, and direct compensation by injector so you can see contribution margin per provider, not just practice-wide. No onboarding fee. 30-day satisfaction guarantee.
Get Started